Results
1 -
10 of
48
(Click
here to explore results)
- Catalyst and solvent switched divergent C–H functionalization: oxidative annulation of N-aryl substituted quinazolin-4-amine with alkynes. Siddi Ramulu Meesa, Praveen Kumar Naikawadi, Kishan Gugulothu, K. Shiva Kumar
, Org. Biomol. Chem.
, 2020
, 18
, 3032
- The design, synthesis and evaluation of selenium-containing 4-anilinoquinazoline hybrids as anticancer agents and a study of their mechanism. Baijiao An, Shun Zhang, Jinhui Hu, Tingting Pan, Ling Huang, Johnny Cheuk-on Tang, Xingshu Li, Albert S. C. Chan
, Org. Biomol. Chem.
, 2018
, 16
, 4701
- Identification of natural flavonoids as novel EGFR inhibitors using DFT, molecular docking, and molecular dynamics. Nayim Sepay, Rina Mondal, Muhanna K. Al-Muhanna, Debajyoti Saha
, New J. Chem.
, 2022
, 46
, 9735
- Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer). Arif Ali, Somesh Banerjee, Saima Kamaal, Mohammad Usman, Neeladrisingha Das, Mohd Afzal, Abdullah Alarifi, Nayim Sepay, Partha Roy, Musheer Ahmad
, RSC Adv.
, 2021
, 11
, 14362
- Luminescent cyclometallated platinum(ii) complexes: highly promising EGFR/DNA probes and dual-targeting anticancer agents. Yang Zhang, Qun Luo, Wei Zheng, Zhaoying Wang, Yu Lin, Erlong Zhang, Shuang Lü, Junfeng Xiang, Yao Zhao, Fuyi Wang
, Inorg. Chem. Front.
, 2018
, 5
, 413
- Design, synthesis, and evaluation of substituted 6-amide-4-anilinoquinazoline derivatives as c-Src inhibitors. Fei Fang, Dong-Dong Li, Jing-Ran Li, Jian Sun, Qian-Ru Du, Hai-Bin Gong, Hai-Liang Zhu
, RSC Adv.
, 2013
, 3
, 26230
- Identification of new hit scaffolds by INPHARMA-guided virtual screening. Justyna Sikorska, Luca Codutti, Lars Skjærven, Bettina Elshorst, Rebeca Saez-Ameneiro, Andrea Angelini, Peter Monecke, Teresa Carlomagno
, Med. Chem. Commun.
, 2015
, 6
, 1501
- Switching from ultrafast electron transfer to proton transfer in excited drug–protein complexes upon biotransformation. Lorena Tamarit, Meryem El Ouardi, Emilio Lence, Inmaculada Andreu, Concepción González-Bello, Ignacio Vayá, Miguel A. Miranda
, Chem. Sci.
, 2022
, 13
, 9644
- Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR. Qingwen Zhang, Yuanyuan Diao, Fei Wang, Ying Fu, Fei Tang, Qidong You, Houyuan Zhou
, Med. Chem. Commun.
, 2013
, 4
, 979
- Dual-targeting organometallic ruthenium(ii) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Yang Zhang, Wei Zheng, Qun Luo, Yao Zhao, Erlong Zhang, Suyan Liu, Fuyi Wang
, Dalton Trans.
, 2015
, 44
, 13100